Initial STP705 Phase I Trial Results Show Fat Reduction
Sirnaomics' STP705 is a drug candidate for fat reduction in adults undergoing abdominoplasty. The STP705 Phase I trial results show signs of efficacy and safety.
Sirnaomics' STP705 is a drug candidate for fat reduction in adults undergoing abdominoplasty. The STP705 Phase I trial results show signs of efficacy and safety.
Synchrony announced that its CareCredit patient financing solution is now fully integrated into Clover point‑of‑sale systems, enabling more than 40,000 health and wellness providers to process patient financing end‑to‑end within their Clover devices.